| Molecular architecture of the SARS-CoV-2 virus H Yao, Y Song, Y Chen, N Wu, J Xu, C Sun, J Zhang, T Weng, Z Zhang, ... Cell 183 (3), 730-738. e13, 2020 | 974 | 2020 |
| Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection H Yao, Y Sun, YQ Deng, N Wang, Y Tan, NN Zhang, XF Li, C Kong, YP Xu, ... Cell research 31 (1), 25-36, 2021 | 75 | 2021 |
| Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo H Yao, X Lu, Q Chen, K Xu, Y Chen, M Cheng, K Chen, L Cheng, T Weng, ... Cell discovery 6 (1), 76, 2020 | 73 | 2020 |
| The lifecycle of the Ebola virus in host cells DS Yu, TH Weng, XX Wu, FXC Wang, XY Lu, HB Wu, NP Wu, LJ Li, ... Oncotarget 8 (33), 55750, 2017 | 53 | 2017 |
| B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer L Shen, Y Qian, W Wu, T Weng, FXC Wang, B Hong, Z Wu, Q Wang, ... Human pathology 66, 79-85, 2017 | 32 | 2017 |
| Dynamic characteristic analysis of antibodies in patients with COVID-19: a 13-month study D Shi, T Weng, J Wu, C Dai, R Luo, K Chen, M Zhu, X Lu, L Cheng, ... Frontiers in Immunology 12, 708184, 2021 | 24 | 2021 |
| MicroRNA expression profiling of pancreatic cancer cell line L3. 6p1 following B7-H4 knockdown Y Qian, L Feng, W Wu, T Weng, C Hu, B Hong, FXC Wang, L Shen, ... Cellular Physiology and Biochemistry 44 (2), 494-504, 2017 | 24 | 2017 |
| Preclinical efficacy of anti-RON antibody–drug conjugate Zt/g4-MMAE for targeted therapy of pancreatic cancer overexpressing RON receptor tyrosine kinase HP Yao, L Feng, TH Weng, CY Hu, SR Suthe, AGM Mostofa, LH Chen, ... Molecular Pharmaceutics 15 (8), 3260-3271, 2018 | 22 | 2018 |
| RON receptor tyrosine kinase as a therapeutic target for eradication of triple-negative breast cancer: efficacy of anti-RON ADC Zt/g4-MMAE SR Suthe, HP Yao, TH Weng, CY Hu, L Feng, ZG Wu, MH Wang Molecular Cancer Therapeutics 17 (12), 2654-2664, 2018 | 20 | 2018 |
| Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy XM Tong, L Feng, SR Suthe, TH Weng, CY Hu, YZ Liu, ZG Wu, MH Wang, ... Journal for immunotherapy of cancer 7, 1-15, 2019 | 19 | 2019 |
| Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer … HP Yao, L Feng, SR Suthe, LH Chen, TH Weng, CY Hu, ES Jun, ZG Wu, ... Journal for ImmunoTherapy of Cancer 7, 1-16, 2019 | 18 | 2019 |
| Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases Y Qian, Y Sang, FXC Wang, B Hong, Q Wang, X Zhou, T Weng, Z Wu, ... Oncotarget 7 (44), 72242, 2016 | 18 | 2016 |
| Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9: viraemia and extrapulmonary infection XX Wu, LZ Zhao, SJ Tang, TH Weng, WG Wu, SH Yao, HB Wu, LF Cheng, ... Emerging microbes & infections 9 (1), 962-975, 2020 | 17 | 2020 |
| RON and MET co-overexpression are significant pathological characteristics of poor survival and therapeutic targets of tyrosine kinase inhibitors in triple-negative breast cancer TH Weng, MY Yao, XM Xu, CY Hu, SH Yao, YZ Liu, ZG Wu, TM Tang, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2020 | 16 | 2020 |
| Preparation of immunochromatographic strips for rapid detection of early secreted protein ESAT-6 and culture filtrate protein CFP-10 from Mycobacterium tuberculosis X Wu, Y Wang, T Weng, C Hu, FXC Wang, Z Wu, D Yu, H Lu, H Yao Medicine 96 (51), e9350, 2017 | 15 | 2017 |
| Aberrant RON and MET co-overexpression as novel prognostic biomarkers of shortened patient survival and therapeutic targets of tyrosine kinase inhibitors in pancreatic cancer CY Hu, XM Xu, B Hong, ZG Wu, Y Qian, TH Weng, YZ Liu, TM Tang, ... Frontiers in Oncology 9, 1377, 2019 | 12 | 2019 |
| The protective effects of the A/ZJU01/PR8/2013 split H7N9 avian influenza vaccine against highly pathogenic H7N9 in BALB/c mice XX Wu, XL Deng, DS Yu, W Yao, HL Ou, TH Weng, CY Hu, FY Hu, NP Wu, ... Cellular Physiology and Biochemistry 46 (2), 633-643, 2018 | 11 | 2018 |
| Chaperones, membrane trafficking and signal transduction proteins regulate Zaire Ebola Virus trVLPs and interact with trVLP elements DS Yu, TH Weng, CY Hu, ZG Wu, YH Li, LF Cheng, NP Wu, LJ Li, HP Yao Frontiers in microbiology 9, 2724, 2018 | 10 | 2018 |
| Longevity of protective immune responses induced by a split influenza A (H7N9) vaccine mixed with MF59 adjuvant in BALB/c mice H Ou, W Yao, D Yu, T Weng, FXC Wang, X Wu, H Wu, L Cheng, X Lu, ... Oncotarget 8 (54), 91828, 2017 | 10 | 2017 |
| Preclinical evaluation of the safety and pathogenicity of a live attenuated recombinant influenza A/H7N9 seed strain and corresponding MF59-adjuvanted split vaccine H Ou, W Yao, N Wu, FXC Wang, T Weng, C Han, X Lu, D Yu, H Wu, ... Oncotarget 7 (49), 81012, 2016 | 10 | 2016 |
